Anti-IL-1a & IL1b Antibody (Lutikizumab)
Catalog No.
F1394
Anti-IL-1a & IL1b Antibody (Lutikizumab)
Featured Products
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β bivariate domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used in osteoarthritis research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
196.8 kDa
Dry ice
1791411-57-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ABT-981
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01583 & P01584
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL 1a, Fc at 2 ug/mL can bind Anti-IL-1a & IL1b Reference Antibody (Lutikizumab)
IL-1a & IL1b
Please avoid freeze-thaw cycles.